Roche Holding AG announced the appointment of Brad Moore as president of Roche Diagnostics North America, effective January 1, 2023. Moore currently serves as senior vice president, Core Lab and Point of Care, within Roche Diagnostics North America. Moore will succeed and report to Matt Sause, who was recently appointed CEO of Roche Diagnostics globally, effective January 1, 2023.

The position will continue to be based at Roche Diagnostics' North American headquarters in Indianapolis. Moore joined Roche in October 2016 as Head of North America Diabetes Care, leading commercial operations for the U.S. and Canada. In 2019, the role expanded to include the broader scope of Europe and North American commercial operations in mature markets in Europe, the U.S., Canada, Australia and New Zealand within Roche Diabetes Care.

In 2020, Moore assumed his current position, leading the newly-created Core Lab and Point of Care commercial business unit.